CN Patent

CN119546306A — 施用贝舒地尔以治疗慢性移植物抗宿主病的方法

Assigned to Kadmon Corp LLC · Expires 2025-02-28 · 1y expired

What this patent protects

本申请提供将贝舒地尔甲磺酸盐给药于cGVHD患者的方法。

USPTO Abstract

本申请提供将贝舒地尔甲磺酸盐给药于cGVHD患者的方法。

Drugs covered by this patent

belumosudil-mesylate (BELUMOSUDIL MESYLATE)

Patent Metadata

Patent number: CN119546306A
Jurisdiction: CN
Classification: —
Expires: 2025-02-28
Drug substance claim: No
Drug product claim: No
Assignee: Kadmon Corp LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.